A Next Generation Theranostic PSMA Ligand for 64Cu and 67Cu-Based Prostate Cancer Imaging and Therapy

被引:0
|
作者
Ponnala, Shashikanth [7 ]
Amor-Coarasa, Alejandro [4 ]
Kelly, James [6 ]
Zia, Nicholas [1 ,2 ]
Clarence, Williams [7 ]
Nikolopoulou, Anastasia [7 ]
Donnelly, Paul [3 ]
Babich, John [5 ]
机构
[1] Univ Melbourne, Sch Chem, Melbourne, Vic, Australia
[2] Univ Melbourne, Bio21 Mol Sci & Biotechnol Inst, Melbourne, Vic, Australia
[3] Univ Melbourne, Melbourne, Vic, Australia
[4] Weill Cornell Med Coll, Bronx, NY USA
[5] Weill Cornell Med Coll, New York, NY USA
[6] Weill Cornell Med, New York, NY USA
[7] Weill Cornell Med, Radiol, New York, NY USA
关键词
D O I
暂无
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
1005
引用
收藏
页数:2
相关论文
共 50 条
  • [1] Preclinical Evaluation of a High-Affinity Sarcophagine-Containing PSMA Ligand for 64Cu/67Cu-Based Theranostics in Prostate Cancer
    Kelly, James M.
    Ponnala, Shashikanth
    Amor-Coarasa, Alejandro
    Zia, Nicholas A.
    Nikolopoulou, Anastasia
    Williams, Clarence, Jr.
    Schlyer, David J.
    DiMagno, Stephen G.
    Donnelly, Paul S.
    Babich, John W.
    MOLECULAR PHARMACEUTICS, 2020, 17 (06) : 1954 - 1962
  • [2] NEXT GENERATION THERANOSTIC PLANNING AND TREATMENT WITH 64CU/67CU
    Bailey, D.
    Schembri, G.
    Willowson, K.
    Hedt, A.
    Lengyelova, E.
    Harris, M.
    INTERNAL MEDICINE JOURNAL, 2019, 49 : 13 - 13
  • [3] A Cu-64/Cu-67 bifunctional PSMA ligand as a theranostic for prostate cancer
    McInnes, Lachlan
    Zia, Nicholas
    Cullinane, Carleen
    Van Zuylekom, Jessica
    Jackson, Susan
    Stoner, Jon
    Haskali, Mohammad
    Roselt, Peter
    Van Dam, Ellen
    Harris, Matthew
    Hicks, Rodney
    Donnelly, Paul
    JOURNAL OF NUCLEAR MEDICINE, 2020, 61
  • [4] Recent Advances in 64Cu/67Cu-Based Radiopharmaceuticals
    Krasnovskaya, Olga O.
    Abramchuck, Daniil
    Erofeev, Alexander
    Gorelkin, Peter
    Kuznetsov, Alexander
    Shemukhin, Andrey
    Beloglazkina, Elena K.
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2023, 24 (11)
  • [5] A Cu-64/Cu-67 Bombesin ligand as a theranostic for cancer
    Huynh, Truc
    Van Dam, Ellen
    Houston, Zachary
    McInnes, Lachlan
    Mpoy, Cedric
    Harris, Matthew
    Thurecht, Kristofer
    Donnelly, Paul
    Rogers, Buck
    JOURNAL OF NUCLEAR MEDICINE, 2021, 62
  • [6] Development of [64Cu]Cu-NGUL and [67Cu]Cu-NGUL as a matched-pair theranostic for prostate cancer
    Seo, Hye Yeon
    Byun, Jung Woo
    Yoo, Ran Ji
    Park, Ji Yong
    Kim, Young Joo
    Kim, Kweon
    Lee, Kyo Chul
    Kim, Jung Young
    Park, Hyun
    Park, Jeong Hoon
    Jung, Jiyoon
    Lee, Myungsu
    Lee, Jooeun
    Jeong, Jae Min
    Lee, Yun-Sang
    NUCLEAR MEDICINE AND BIOLOGY, 2022, 114 : S61 - S61
  • [7] A Sarcophagine Containing PSMA Ligand for Targeting Prostate Cancer with 64/67Cu
    Kelly, J. M.
    Ponnala, S.
    Nikolopoulou, A.
    Zia, N.
    Williams, C., Jr.
    Donnelly, P. S.
    Babich, J. W.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2019, 46 (SUPPL 1) : S14 - S15
  • [8] Harnessing 64Cu/67Cu for a theranostic approach to pretargeted radioimmunotherapy
    Keinanen, Outi
    Fung, Kimberly
    Brennan, James M.
    Zia, Nicholas
    Harris, Matt
    van Dam, Ellen
    Biggin, Colin
    Hedt, Amos
    Stoner, Jon
    Donnelly, Paul S.
    Lewis, Jason S.
    Zeglis, Brian M.
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2020, 117 (45) : 28316 - 28327
  • [9] [64Cu]Cu-ATSM: an emerging theranostic agent for cancer and neuroinflammation
    Fang Xie
    Weijun Wei
    European Journal of Nuclear Medicine and Molecular Imaging, 2022, 49 : 3964 - 3972
  • [10] [64Cu]Cu-ATSM: an emerging theranostic agent for cancer and neuroinflammation
    Xie, Fang
    Wei, Weijun
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2022, 49 (12) : 3964 - 3972